-
Something wrong with this record ?
Antimicrobial resistance: Concerns of healthcare providers and people with CF
W. Bullington, S. Hempstead, AR. Smyth, P. Drevinek, L. Saiman, VJ. Waters, SC. Bell, DR. VanDevanter, PA. Flume, S. Elborn, MS. Muhlebach, Antimicrobial Resistance International Working Group in Cystic Fibrosis
Language English Country Netherlands
Document type Journal Article
- MeSH
- Antimicrobial Stewardship * MeSH
- Drug Resistance, Bacterial * MeSH
- Cystic Fibrosis microbiology MeSH
- Burkholderia Infections drug therapy MeSH
- Humans MeSH
- Patients psychology MeSH
- Surveys and Questionnaires MeSH
- Pseudomonas Infections drug therapy MeSH
- Health Knowledge, Attitudes, Practice * MeSH
- Health Personnel psychology MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Chronic lung infections and their treatment pose risks for the development of antimicrobial resistance (AMR) in people with cystic fibrosis (PWCF). In this study, we evaluated the attitudes of healthcare providers' (HCP) and PWCF or their parents' toward AMR within the international CF community. METHODS: HCP and PWCF identified through listservs and CF-related organizations were asked to complete an AMR centered survey, with additional questions on antimicrobial stewardship (AMS) for HCP. Descriptive analyses are reported. RESULTS: The responding 443 HCP and 464 PWCF/Parents were from 30 and 25 countries, respectively. Sixty-two percent of HCP and 56% of PWCF stated they were "very concerned" about AMR, with Pseudomonas spp. and Burkholderia spp. considered the most concerning organisms for both HCP and PWCF/Parents. Non-tuberculous mycobacteria were of greater concern to HCP compared to PWCF/Parents. There was a discrepancy regarding AMR education to PWCF, with 80% of HCP stating having discussed this with PWCF/Parents, but only 50% of PWCF recalling such discussions. CONCLUSION: These results highlight that AMR is relevant to CF HCP and PWCF internationally, indicating that educational tools and research are warranted.
Cystic Fibrosis Foundation Bethesda MD USA
Department of Pediatrics Case Western Reserve University School of Medicine Cleveland OH USA
Department of Pediatrics Columbia University New York New York USA
Department of Pediatrics University of North Carolina Chapel Hill NC USA
Department of Pharmacy Services Medical University of South Carolina Charleston SC USA
Departments of Medicine and Pediatrics Medical University of South Carolina Charleston SC USA
Imperial College and Royal Brompton Hospital London and Queen's University Belfast United Kingdom
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012451
- 003
- CZ-PrNML
- 005
- 20220506130331.0
- 007
- ta
- 008
- 220425s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jcf.2020.05.009 $2 doi
- 035 __
- $a (PubMed)32563724
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Bullington, Wendy $u Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC, USA. Electronic address: bullingw@musc.edu
- 245 10
- $a Antimicrobial resistance: Concerns of healthcare providers and people with CF / $c W. Bullington, S. Hempstead, AR. Smyth, P. Drevinek, L. Saiman, VJ. Waters, SC. Bell, DR. VanDevanter, PA. Flume, S. Elborn, MS. Muhlebach, Antimicrobial Resistance International Working Group in Cystic Fibrosis
- 520 9_
- $a BACKGROUND: Chronic lung infections and their treatment pose risks for the development of antimicrobial resistance (AMR) in people with cystic fibrosis (PWCF). In this study, we evaluated the attitudes of healthcare providers' (HCP) and PWCF or their parents' toward AMR within the international CF community. METHODS: HCP and PWCF identified through listservs and CF-related organizations were asked to complete an AMR centered survey, with additional questions on antimicrobial stewardship (AMS) for HCP. Descriptive analyses are reported. RESULTS: The responding 443 HCP and 464 PWCF/Parents were from 30 and 25 countries, respectively. Sixty-two percent of HCP and 56% of PWCF stated they were "very concerned" about AMR, with Pseudomonas spp. and Burkholderia spp. considered the most concerning organisms for both HCP and PWCF/Parents. Non-tuberculous mycobacteria were of greater concern to HCP compared to PWCF/Parents. There was a discrepancy regarding AMR education to PWCF, with 80% of HCP stating having discussed this with PWCF/Parents, but only 50% of PWCF recalling such discussions. CONCLUSION: These results highlight that AMR is relevant to CF HCP and PWCF internationally, indicating that educational tools and research are warranted.
- 650 12
- $a antibiotická politika $7 D000073602
- 650 _2
- $a infekce bakteriemi rodu Burkholderia $x farmakoterapie $7 D019121
- 650 _2
- $a cystická fibróza $x mikrobiologie $7 D003550
- 650 12
- $a bakteriální léková rezistence $7 D024881
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a zdraví - znalosti, postoje, praxe $7 D007722
- 650 _2
- $a zdravotnický personál $x psychologie $7 D006282
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pacienti $x psychologie $7 D010361
- 650 _2
- $a pseudomonádové infekce $x farmakoterapie $7 D011552
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hempstead, Sarah $u Cystic Fibrosis Foundation, Bethesda, MD, USA. Electronic address: shempstead@cff.org
- 700 1_
- $a Smyth, Alan R $u Division of Child Health, Obstetrics & Gynaecology, University of Nottingham, Nottingham, United Kingdom. Electronic address: Alan.Smyth@nottingham.ac.uk
- 700 1_
- $a Drevinek, Pavel $u Departments of Medical Microbiology Motol University Hospital and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: pavel.drevinek@lfmotol.cuni.cz
- 700 1_
- $a Saiman, Lisa $u Department of Pediatrics, Columbia University, New York, New York, USA. Electronic address: ls5@cumc.columbia.edu
- 700 1_
- $a Waters, Valerie J $u Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada. Electronic address: Valerie.Waters@sickkids.ca
- 700 1_
- $a Bell, Scott C $u Department of Thoracic Medicine, The Prince Charles Hospital and QIMR Berghofer Medical Research Institute, Brisbane, Australia. Electronic address: scott.bell@health.qld.gov.au
- 700 1_
- $a VanDevanter, Donald R $u Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: drv15@case.edu
- 700 1_
- $a Flume, Patrick A $u Departments of Medicine and Pediatrics, Medical University of South Carolina, Charleston, SC, USA. Electronic address: flumepa@musc.edu
- 700 1_
- $a Elborn, Stuart $u Imperial College and Royal Brompton Hospital, London and Queen's University Belfast, United Kingdom. Electronic address: s.elborn@qub.ac.uk
- 700 1_
- $a Muhlebach, Marianne S $u Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA. Electronic address: marianne_muhlebach@med.unc.edu
- 710 2_
- $a Antimicrobial Resistance International Working Group in Cystic Fibrosis
- 773 0_
- $w MED00006892 $t Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society $x 1873-5010 $g Roč. 20, č. 3 (2021), s. 407-412
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32563724 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130323 $b ABA008
- 999 __
- $a ok $b bmc $g 1789869 $s 1163652
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 20 $c 3 $d 407-412 $e 20200617 $i 1873-5010 $m Journal of cystic fibrosis $n J Cyst Fibros $x MED00006892
- LZP __
- $a Pubmed-20220425
